002007 华兰生物
已收盘 09-30 15:00:00
资讯
新帖
简况
华兰生物(002007)9月29日主力资金净卖出230.04万元
证券之星 · 09-30
华兰生物(002007)9月29日主力资金净卖出230.04万元
股市必读:华兰生物新发布《2026年第一次临时股东会法律意见书》
证券之星 · 09-30
股市必读:华兰生物新发布《2026年第一次临时股东会法律意见书》
华兰生物(002007)披露2026年第一次临时股东会决议公告,9月28日股价上涨0.61%
证券之星 · 09-28
华兰生物(002007)披露2026年第一次临时股东会决议公告,9月28日股价上涨0.61%
华兰生物:公司将结合自身公司实际情况与市场环境审慎评估
证券之星 · 09-24
华兰生物:公司将结合自身公司实际情况与市场环境审慎评估
华兰生物:血液制品、疫苗、重组蛋白药物三大核心板块
证券之星 · 09-24
华兰生物:血液制品、疫苗、重组蛋白药物三大核心板块
股市必读:华兰生物新发布《关于参股公司收到药品注册受理通知书的公告》
证券之星 · 09-24
股市必读:华兰生物新发布《关于参股公司收到药品注册受理通知书的公告》
华兰生物:新型流感病毒mRNA疫苗已取得药物临床试验批准通知书
证券之星 · 09-20
华兰生物:新型流感病毒mRNA疫苗已取得药物临床试验批准通知书
华兰生物:截至2026年9月10日,公司共有14万多名投资者
证券之星 · 09-20
华兰生物:截至2026年9月10日,公司共有14万多名投资者
华兰生物:截至2026年8月31日,公司共有14.1万多名投资者
证券之星 · 09-09
华兰生物:截至2026年8月31日,公司共有14.1万多名投资者
股市必读:华兰生物中报 - 第二季度单季净利润同比下降24.53%
证券之星 · 08-31
股市必读:华兰生物中报 - 第二季度单季净利润同比下降24.53%
华兰生物(002007)2026年中报简析:净利润同比下降25.69%
证券之星 · 08-30
华兰生物(002007)2026年中报简析:净利润同比下降25.69%
华兰生物(002007)披露召开2026年第一次临时股东大会通知,8月28日股价下跌0.98%
证券之星 · 08-28
华兰生物(002007)披露召开2026年第一次临时股东大会通知,8月28日股价下跌0.98%
图解华兰生物中报:第二季度单季净利润同比下降24.53%
证券之星 · 08-28
图解华兰生物中报:第二季度单季净利润同比下降24.53%
华兰生物(002007)7月31日股东户数14万户,较上期减少4.11%
证券之星 · 08-28
华兰生物(002007)7月31日股东户数14万户,较上期减少4.11%
股市必读:华兰生物(002007)8月11日董秘有最新回复
证券之星 · 08-12
股市必读:华兰生物(002007)8月11日董秘有最新回复
华兰生物:2024-2026年每年现金分红额不低于当年净利润的30%
证券之星 · 08-11
华兰生物:2024-2026年每年现金分红额不低于当年净利润的30%
股市必读:华兰生物(002007)股东户数14万户,较上期减少4.11%
证券之星 · 08-11
股市必读:华兰生物(002007)股东户数14万户,较上期减少4.11%
华兰生物:公司控股子公司华兰疫苗正在开展新型流感病毒mRNA疫苗的研发工作
证券之星 · 08-10
华兰生物:公司控股子公司华兰疫苗正在开展新型流感病毒mRNA疫苗的研发工作
华兰生物:截至2026年7月31日,公司共有14万多名投资者
证券之星 · 08-10
华兰生物:截至2026年7月31日,公司共有14万多名投资者
华兰生物(002007)披露高级管理人员辞职公告,7月17日股价下跌3.51%
证券之星 · 07-17
华兰生物(002007)披露高级管理人员辞职公告,7月17日股价下跌3.51%
加载更多
公司概况
公司名称:
华兰生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2004-06-25
主营业务:
华兰生物工程股份有限公司的主营业务是血液制品、疫苗、创新药和生物类似药的研发、生产和销售。公司的主要产品是人血白蛋白、静注人免疫球蛋白、人免疫球蛋白、人凝血酶原复合物、人凝血因子Ⅷ、人纤维蛋白原、狂犬病人免疫球蛋白、乙型肝炎人免疫球蛋白、破伤风人免疫球蛋白。“华兰”商标被认定为中国驰名商标,公司荣膺“国家高新技术产业化示范工程企业”“河南省先进高新技术企业”“河南省高新技术产业化项目实施先进单位”等称号。
发行价格:
15.74
{"stockData":{"symbol":"002007","market":"SZ","secType":"STK","nameCN":"华兰生物","latestPrice":13.34,"timestamp":1790751831000,"preClose":13.02,"halted":0,"volume":12423712,"delay":0,"changeRate":0.0246,"floatShares":1574000000,"shares":1826000000,"eps":0.4426,"marketStatus":"已收盘","change":0.32,"latestTime":"09-30 15:00:00","open":13.05,"high":13.37,"low":13.02,"amount":165000000,"amplitude":0.0269,"askPrice":13.34,"askSize":552,"bidPrice":13.33,"bidSize":177,"shortable":0,"etf":0,"ttmEps":0.4426,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":13.02,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":14.32,"lowLimit":11.72,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1825690986,"isCdr":false,"pbRate":2.17,"roa":"--","peRate":30.140081,"roe":"3.32%","epsLYR":0.5151,"committee":-0.780895,"marketValue":24355000000,"turnoverRate":0.0079,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-10-08。","floatMarketCap":20991000000},"requestUrl":"/m/hq/s/002007","defaultTab":"news","newsList":[{"id":"2671229879","title":"华兰生物(002007)9月29日主力资金净卖出230.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671229879","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671229879?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:19","pubTimestamp":1790731142,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月29日收盘,华兰生物报收于13.02元,下跌1.29%,换手率0.48%,成交量7.58万手,成交额9912.92万元。近5日资金流向一览见下表:华兰生物融资融券信息显示,融资方面,当日融资买入758.09万元,融资偿还926.72万元,融资净偿还168.63万元。融券方面,融券卖出7200.0股,融券偿还7700.0股,融券余量78.46万股,融券余额1021.55万元。华兰生物主营业务:血液制品、疫苗、基因工程产品研发、生产和销售的国家高新技术企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000007864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0028","BK0046","BK0185","BK0197","BK0239","002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224143","title":"股市必读:华兰生物新发布《2026年第一次临时股东会法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671224143?lang=zh_cn&edition=full","pubTime":"2026-09-30 02:16","pubTimestamp":1790705772,"startTime":"0","endTime":"0","summary":"公司公告汇总:华兰生物2026年第一次临时股东会审议通过《关于2026年上半年度利润分配的预案》,中小股东同意占比97.2228%。公司公告汇总2026年第一次临时股东会法律意见书安徽承义律师事务所出具法律意见书,认为华兰生物工程股份有限公司2026年第一次临时股东会的召集、召开程序、出席人员资格、提案、表决程序及表决结果均符合法律法规和公司章程规定,会议决议合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002007","BK0028","BK0188","BK0239","BK0197","BK0046","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670269255","title":"华兰生物(002007)披露2026年第一次临时股东会决议公告,9月28日股价上涨0.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670269255","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670269255?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:43","pubTimestamp":1790606598,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘,华兰生物报收于13.19元,较前一交易日上涨0.61%,最新总市值为240.81亿元。近日,华兰生物发布2026年第一次临时股东会决议公告。公告显示,公司于2026年9月28日召开2026年第一次临时股东会,会议采用现场与网络投票相结合方式召开,出席会议股东共743人,代表股份886,206,424股,占公司有表决权股份总数的48.5409%。其中,利润分配预案获得总表决同意股数占比99.8618%,中小股东同意占比97.2228%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0046","BK0239","BK0028","BK0077","002007","BK0185","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669498039","title":"华兰生物:公司将结合自身公司实际情况与市场环境审慎评估","url":"https://stock-news.laohu8.com/highlight/detail?id=2669498039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669498039?lang=zh_cn&edition=full","pubTime":"2026-09-24 20:51","pubTimestamp":1790254289,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰生物(002007)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问:现在上市药企掀起了有一次大规模回购,公司考虑过相关措施吗?华兰生物回复:尊敬的投资者,您好!感谢您的建议,公司将结合自身公司实际情况与市场环境审慎评估,后续若有股份回购计划,将严格按照法律法规要求及时履行信息披露义务。同时,公司管理层持续加大技术创新力度、努力做好公司经营、坚持每年分红持续做好投资者回报,努力提升公司投资价值。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400038302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","002007","BK0077","BK0185","BK0197","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669457314","title":"华兰生物:血液制品、疫苗、重组蛋白药物三大核心板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2669457314","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669457314?lang=zh_cn&edition=full","pubTime":"2026-09-24 15:07","pubTimestamp":1790233638,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰生物09月24日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400021173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0046","159646","BK0185","BK0239","BK0028","BK0188","002007","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669387224","title":"股市必读:华兰生物新发布《关于参股公司收到药品注册受理通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669387224","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669387224?lang=zh_cn&edition=full","pubTime":"2026-09-24 01:52","pubTimestamp":1790185935,"startTime":"0","endTime":"0","summary":"公司公告汇总关于参股公司收到药品注册受理通知书的公告2026年9月22日,华兰生物参股公司华兰安康生物股份有限公司收到国家药品监督管理局下发的《受理通知书》,其提交的注射用曲妥珠单抗上市许可申请获得受理。该药品为治疗用生物制品3.3类,适应症为HER2阳性的早期乳腺癌、转移性乳腺癌、转移性胃癌。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0185","BK0197","BK0028","002007","BK0239","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668183254","title":"华兰生物:新型流感病毒mRNA疫苗已取得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2668183254","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668183254?lang=zh_cn&edition=full","pubTime":"2026-09-20 16:03","pubTimestamp":1789891389,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰生物(002007)09月20日在投资者关系平台上答复投资者关心的问题。投资者提问:莫德纳的mRNA黑色素瘤疫苗获得市场的热捧,同样基于mRNA技术平台和K药,公司都有涉足,是否有未来会把治疗性疫苗纳入研发范围?或相关发展规划?华兰生物回复:您好,公司控股子公司华兰疫苗的新型流感病毒mRNA疫苗已取得药物临床试验批准通知书。公司研发项目情况请以公司公告为准。感谢您对公司的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000003364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0197","BK0185","002007","BK0188","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668832571","title":"华兰生物:截至2026年9月10日,公司共有14万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2668832571","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668832571?lang=zh_cn&edition=full","pubTime":"2026-09-20 16:00","pubTimestamp":1789891244,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰生物(002007)09月20日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2026年9月10日,公司股东人数多少?华兰生物回复:您好,截至2026年9月10日,公司共有14万多名投资者,感谢您对公司的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000003245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","BK0185","BK0197","BK0239","BK0188","BK0028","002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666760586","title":"华兰生物:截至2026年8月31日,公司共有14.1万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2666760586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666760586?lang=zh_cn&edition=full","pubTime":"2026-09-09 16:54","pubTimestamp":1788944049,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰生物(002007)09月09日在投资者关系平台上答复投资者关心的问题。投资者提问:请问8月31日股东人数是多少?谢谢华兰生物回复:您好,截至2026年8月31日,公司共有14.1万多名投资者,感谢您对公司的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900028206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0197","BK0077","BK0028","002007","BK0185","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663055040","title":"股市必读:华兰生物中报 - 第二季度单季净利润同比下降24.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663055040","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663055040?lang=zh_cn&edition=full","pubTime":"2026-08-31 07:29","pubTimestamp":1788132551,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,华兰生物报收于13.15元,下跌0.98%,换手率0.44%,成交量6.95万手,成交额9141.15万元。股本股东变化:截至2026年7月31日股东户数为14.0万户,较4月30日减少6000户,减幅4.11%。业绩披露要点:2026年中报显示主营收入15.67亿元,同比下降12.88%;归母净利润3.83亿元,同比下降25.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048214","title":"华兰生物(002007)2026年中报简析:净利润同比下降25.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048214?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:22","pubTimestamp":1788042167,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期华兰生物发布2026年中报。根据财报显示,华兰生物净利润同比下降25.69%。截至本报告期末,公司营业总收入15.67亿元,同比下降12.88%,归母净利润3.83亿元,同比下降25.69%。去年的净利率为21.76%,算上全部成本后,公司产品或服务的附加值高。持有华兰生物最多的基金为疫苗ETF国泰,目前规模为1.4亿元,最新净值0.5633,较上一交易日下跌2.15%,近一年下跌14.07%。本文数据来源于华兰生物2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662784099","title":"华兰生物(002007)披露召开2026年第一次临时股东大会通知,8月28日股价下跌0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662784099","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662784099?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:20","pubTimestamp":1787926830,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,华兰生物报收于13.15元,较前一交易日下跌0.98%,最新总市值为240.08亿元。近日,华兰生物工程股份有限公司披露《关于召开2026年第一次临时股东会的通知》。公告显示,公司将于2026年9月28日召开2026年第一次临时股东会,会议由董事会召集,现场会议时间为当日14:30,网络投票时间为当日9:15至15:00。股权登记日为2026年9月22日。登记时间为2026年9月23日至24日,可通过现场、信函、传真或邮件方式登记。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800054628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0046","BK0077","BK0197","BK0239","BK0185","002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061236","title":"图解华兰生物中报:第二季度单季净利润同比下降24.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061236","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662061236?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:26","pubTimestamp":1787912763,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰生物2026年中报显示,上半年度公司主营收入15.67亿元,同比下降12.88%;归母净利润3.83亿元,同比下降25.69%;扣非净利润3.42亿元,同比下降29.35%;其中2026年第二季度,公司单季度主营收入8.05亿元,同比下降13.55%;单季度归母净利润1.53亿元,同比下降24.53%;单季度扣非净利润1.15亿元,同比下降37.52%;负债率12.68%,投资收益9753.37万元,财务费用-300.49万元,毛利率46.2%。财报数据概要请见下图:本文数据来源于华兰生物2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800043403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662181066","title":"华兰生物(002007)7月31日股东户数14万户,较上期减少4.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662181066","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662181066?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:46","pubTimestamp":1787910363,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华兰生物披露,截至2026年7月31日公司股东户数为14.0万户,较4月30日减少6000.0户,减幅为4.11%。在生物制品行业个股中,华兰生物股东户数高于行业平均水平,截至7月31日,生物制品行业平均股东户数为3.54万户。从股价来看,2026年4月30日至2026年7月31日,华兰生物区间跌幅为3.19%,在此期间股东户数减少6000.0户,减幅为4.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800041040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0197","BK0188","002007","BK0077","BK0185","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658991792","title":"股市必读:华兰生物(002007)8月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2658991792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658991792?lang=zh_cn&edition=full","pubTime":"2026-08-12 02:10","pubTimestamp":1786471824,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘,华兰生物报收于13.37元,下跌0.22%,换手率0.73%,成交量11.55万手,成交额1.55亿元。董秘最新回复投资者: 你好,公司这样分红可持久么。2027、2028、2029、2030预计分红是盈利点多少?目前公司尚未制定2027年及以后年度的具体分红计划,未来将结合经营业绩、现金流状况及发展需求合理制定分红政策。当日关注点交易信息汇总:8月11日主力资金净流入252.41万元,占总成交额1.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200002086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0197","BK0185","002007","BK0239","BK0028","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658796704","title":"华兰生物:2024-2026年每年现金分红额不低于当年净利润的30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658796704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658796704?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:04","pubTimestamp":1786431855,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰生物08月11日在投资者关系平台上答复投资者关心的问题。华兰生物回复:尊敬的投资者您好,公司始终坚持稳健的分红政策,2024年发布的《未来三年股东回报规划》明确:在符合现金分红条件下,2024-2026年每年现金分红额不低于当年净利润的30%或三年现金分红总额不低于2024-2026年净利润总额的30%。目前公司尚未制定2027年及以后年度的具体分红计划,未来将结合经营业绩、现金流状况及发展需求合理制定分红政策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100018869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658580109","title":"股市必读:华兰生物(002007)股东户数14万户,较上期减少4.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658580109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658580109?lang=zh_cn&edition=full","pubTime":"2026-08-11 01:18","pubTimestamp":1786382306,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘,华兰生物报收于13.4元,下跌0.22%,换手率0.91%,成交量14.38万手,成交额1.94亿元。股本股东变化:截至2026年7月31日,华兰生物股东户数为14.0万户,较4月30日减少6000.0户,减幅4.11%。户均持股数量由上期的1.25万股增加至1.3万股,户均持股市值为17.53万元。董秘最新回复投资者: 请问公司2026年7月31日A股股东人数是多少?谢谢董秘: 您好,截至2026年7月31日,公司共有14万多名投资者,感谢您对公司的关注!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100001241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0028","BK0188","BK0046","BK0239","BK0197","002007","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985749","title":"华兰生物:公司控股子公司华兰疫苗正在开展新型流感病毒mRNA疫苗的研发工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985749","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985749?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:30","pubTimestamp":1786347046,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰生物(002007)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司是否有研发mRNA流感疫苗?华兰生物回复:您好,公司控股子公司华兰疫苗正在开展新型流感病毒mRNA疫苗的研发工作,疫苗研发存在不确定性,敬请投资者注意投资风险。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000013882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","301207","BK0077","BK0197","002007","BK0046","BK0185","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658983754","title":"华兰生物:截至2026年7月31日,公司共有14万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2658983754","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658983754?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:08","pubTimestamp":1786345704,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰生物(002007)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司2026年7月31日A股股东人数是多少?谢谢华兰生物回复:您好,截至2026年7月31日,公司共有14万多名投资者,感谢您对公司的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000013403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0046","002007","BK0185","BK0188","BK0239","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652898602","title":"华兰生物(002007)披露高级管理人员辞职公告,7月17日股价下跌3.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652898602","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652898602?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:14","pubTimestamp":1784297657,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,华兰生物报收于13.18元,较前一交易日下跌3.51%,最新总市值为240.63亿元。近日,华兰生物工程股份有限公司披露《关于高级管理人员辞职的公告》。公告显示,公司董事会收到高级管理人员陈正跃先生提交的书面辞职报告。其辞职报告自送达董事会之日起生效,不影响公司相关工作正常进行。截至公告日,陈正跃先生持有公司股票34,000股,将继续遵守有关离任高管减持股份的法律法规。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700044686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","BK0188","BK0197","BK0239","002007","BK0185","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791048508953,"stockEarnings":[{"period":"1week","weight":0.003},{"period":"1month","weight":0.0199},{"period":"3month","weight":0.0471},{"period":"6month","weight":-0.0516},{"period":"1year","weight":-0.1028},{"period":"ytd","weight":-0.0842}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华兰生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"140000人(较上一季度减少0.71%)","perCapita":"11239股","listingDate":"2004-06-25","address":"河南省新乡市红旗区华兰大道甲1号","registeredCapital":"182569万元","survey":" 华兰生物工程股份有限公司的主营业务是血液制品、疫苗、创新药和生物类似药的研发、生产和销售。公司的主要产品是人血白蛋白、静注人免疫球蛋白、人免疫球蛋白、人凝血酶原复合物、人凝血因子Ⅷ、人纤维蛋白原、狂犬病人免疫球蛋白、乙型肝炎人免疫球蛋白、破伤风人免疫球蛋白。“华兰”商标被认定为中国驰名商标,公司荣膺“国家高新技术产业化示范工程企业”“河南省先进高新技术企业”“河南省高新技术产业化项目实施先进单位”等称号。","listedPrice":15.74},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰生物,002007,华兰生物股票,华兰生物股票老虎,华兰生物股票老虎国际,华兰生物行情,华兰生物股票行情,华兰生物股价,华兰生物股市,华兰生物股票价格,华兰生物股票交易,华兰生物股票购买,华兰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}